Published in Neurology on September 18, 2007
Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain (2008) 2.02
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry (2014) 1.65
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler (2011) 1.51
Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol (2011) 1.51
The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology (2013) 1.48
Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry (2008) 1.38
Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain (2008) 1.37
Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One (2012) 1.26
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging (2011) 1.24
The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology (2010) 1.22
Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry. J Neurol Sci (2009) 1.11
Core features of frontotemporal dementia recapitulated in progranulin knockout mice. Neurobiol Dis (2011) 1.10
Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol (2009) 1.08
3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage (2009) 1.04
Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol (2011) 1.03
Cognitive dysfunction in pediatric multiple sclerosis. Neuropsychiatr Dis Treat (2014) 0.99
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry (2014) 0.97
Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis. J Neurosci (2011) 0.97
MRI predictors of cognitive outcome in early multiple sclerosis. Neurology (2011) 0.95
Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol (2012) 0.94
Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci (2010) 0.93
Cognition in multiple sclerosis: relevance of lesions, brain atrophy and proton MR spectroscopy. Neurol Sci (2010) 0.93
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy. Front Neurol (2013) 0.92
Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci (2009) 0.91
Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLoS One (2012) 0.88
Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm (2015) 0.87
Cognitive and clinical dysfunction, altered MEG resting-state networks and thalamic atrophy in multiple sclerosis. PLoS One (2013) 0.87
Neuroimaging in multiple sclerosis: neurotherapeutic implications. Neurotherapeutics (2011) 0.85
Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors. J Neuroimaging (2014) 0.84
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis. Neuroimage Clin (2014) 0.83
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. Mult Scler Int (2014) 0.83
Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis. PLoS One (2014) 0.83
Higher education moderates the effect of T2 lesion load and third ventricle width on cognition in multiple sclerosis. PLoS One (2014) 0.82
Current and new directions in MRI in multiple sclerosis. Continuum (Minneap Minn) (2013) 0.82
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations. Mult Scler Int (2013) 0.80
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis. Neuroimage Clin (2013) 0.80
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. J Neurol (2014) 0.79
Imaging as an Outcome Measure in Multiple Sclerosis. Neurotherapeutics (2016) 0.79
Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology. Mult Scler (2015) 0.79
Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data. Mult Scler Relat Disord (2015) 0.78
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method. PLoS One (2016) 0.78
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis. PLoS One (2015) 0.78
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment. Magn Reson Imaging (2013) 0.78
Overall Memory Impairment Identification with Mathematical Modeling of the CVLT-II Learning Curve in Multiple Sclerosis. Mult Scler Int (2012) 0.78
Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis. J Neuroimaging (2014) 0.78
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis. Neuroimage Clin (2015) 0.78
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging. Brain Behav (2016) 0.77
Extra-hippocampal subcortical limbic involvement predicts episodic recall performance in multiple sclerosis. PLoS One (2012) 0.77
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis. BMC Med (2013) 0.77
Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data. AJNR Am J Neuroradiol (2009) 0.77
Evidencing different neurochemical profiles between thalamic nuclei using high resolution 2D-PRESS semi-LASER (1)H-MRSI at 7 T. MAGMA (2016) 0.77
Short-latency afferent inhibition predicts verbal memory performance in patients with multiple sclerosis. J Neurol (2008) 0.76
Focal brain atrophy in gastric bypass patients with cognitive complaints. J Clin Neurosci (2011) 0.76
Putaminal alteration in multiple sclerosis patients with spinal cord lesions. J Neural Transm (Vienna) (2015) 0.76
Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST). Neuroimage Clin (2014) 0.76
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population. Neurol Sci (2016) 0.75
Outcome Measures in Clinical Trials for Multiple Sclerosis. CNS Drugs (2017) 0.75
The Contribution of Cortical Lesions to a Composite MRI Scale of Disease Severity in Multiple Sclerosis. Front Neurol (2016) 0.75
Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis. Neural Regen Res (2013) 0.75
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis. Neurol Ther (2016) 0.75
Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads. Neuropsychiatr Dis Treat (2011) 0.75
Gray Matter Changes in Demyelinating Disease: Correlations with Clinical Scores. Maedica (Buchar) (2015) 0.75
Thalamic Atrophy Contributes to Low Slow Wave Sleep in Neuromyelitis Optica Spectrum Disorder. Aging Dis (2016) 0.75
Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis. Neuroimage Clin (2016) 0.75
Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. PLoS One (2016) 0.75
Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature. PLoS One (2017) 0.75
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice. Neurol Ther (2014) 0.75
3D shape analysis of the brain's third ventricle using a midplane encoded symmetric template model. Comput Methods Programs Biomed (2016) 0.75
The clinico-radiological paradox of cognitive function and MRI burden of white matter lesions in people with multiple sclerosis: A systematic review and meta-analysis. PLoS One (2017) 0.75
Thalamus segmentation using multi-modal feature classification: Validation and pilot study of an age-matched cohort. Neuroimage (2017) 0.75
Targeting Cognitive Impairment in Multiple Sclerosis-The Road toward an Imaging-based Biomarker. Front Neurosci (2017) 0.75
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 15.44
Typhoid fever in children aged less than 5 years. Lancet (1999) 6.00
Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med (2001) 5.90
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology (2011) 5.16
Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen. Mol Cell Biol (1989) 5.01
Venous angioplasty in patients with multiple sclerosis: results of a pilot study. Eur J Vasc Endovasc Surg (2011) 4.68
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology (2011) 3.62
The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity (1997) 3.44
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg (2001) 3.03
Natural transmission of Plasmodium knowlesi to humans by Anopheles latens in Sarawak, Malaysia. Trans R Soc Trop Med Hyg (2006) 2.94
Seasonal prevalence of MS disease activity. Neurology (2010) 2.59
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
Adaptation-induced plasticity of orientation tuning in adult visual cortex. Neuron (2000) 2.47
Potential impact of chemical prophylaxis on the incidence of gonorrhoea. Br J Vener Dis (1972) 2.37
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
Significance of hyperintense vessels on FLAIR MRI in acute stroke. Neurology (2000) 2.27
Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol (1990) 2.26
Seroprevalence of HIV infection in rural South Africa. AIDS (1992) 2.22
A seven-year field trial of two typhoid vaccines in Guyana. Lancet (1967) 2.20
MRI findings in Susac's syndrome. Neurology (2003) 2.17
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) Neurology (1998) 2.16
Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry (1999) 2.14
Additional renal arteries: incidence and morphometry. Surg Radiol Anat (2001) 2.12
Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. Mol Biochem Parasitol (2000) 2.12
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity (1996) 2.09
Escherichia coli has two homologous glutamate decarboxylase genes that map to distinct loci. J Bacteriol (1992) 2.08
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes (1990) 2.04
An operational definition for spatial disorientation. Aviat Space Environ Med (1994) 2.02
Left renal vein variations. Surg Radiol Anat (1999) 2.00
Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology (2002) 2.00
Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test. Mult Scler (2007) 1.99
Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology (1997) 1.99
Cloning of Giardia lamblia heat shock protein HSP70 homologs: implications regarding origin of eukaryotic cells and of endoplasmic reticulum. Proc Natl Acad Sci U S A (1994) 1.91
Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology (2011) 1.89
Increased sensitivity of malaria detection by nested polymerase chain reaction using simple sampling and DNA extraction. Int J Parasitol (1997) 1.83
Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg (1995) 1.83
CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol (2001) 1.82
Outcome and complications of treatment of ankle diastasis with tightrope fixation. Injury (2009) 1.81
Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol (2002) 1.81
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol (2000) 1.74
Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med (2000) 1.67
The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol (2009) 1.62
Quantitative measurement of abnormal retinal correspondence. Br J Ophthalmol (1969) 1.61
Microbial degradation of tannins--a current perspective. Biodegradation (1998) 1.58
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol (2001) 1.57
Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation. Inflamm Res (2007) 1.55
Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating Protein (TRAP). J Biol Chem (2001) 1.55
A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis. Neurology (1998) 1.52
Glycosylation of bacterial cellulases prevents proteolytic cleavage between functional domains. FEBS Lett (1987) 1.52
Correlation between rotator cuff tears and repeated subacromial steroid injections: a case-controlled study. Ann R Coll Surg Engl (2009) 1.51
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler (2011) 1.51
Ventricular arrhythmias in ischemic heart disease. Ann Intern Med (1991) 1.50
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain (2009) 1.50
Predicting short-term disability in multiple sclerosis. Neurology (2007) 1.46
A case of extensive block during spinal anaesthesia for caesarean delivery: is there some room to go wrong? Int J Obstet Anesth (2004) 1.45
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Postdisaster morbidity of the bereaved. A possible role for preventive psychiatry? J Nerv Ment Dis (1981) 1.44
Patient education videos for elective colorectal surgery: results of a randomized controlled trial. Colorectal Dis (2013) 1.44
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol (1993) 1.42
Antimicrobial resistance pattern and in-vitro activity of azithromycin in Salmonella isolates [corrected]. Indian J Med Microbiol (2013) 1.42
Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. J Neurol Sci (2009) 1.41
Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med (2003) 1.41
A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency caesarean section. Can J Anaesth (1995) 1.40
Percutaneous transluminal myocardial revascularization with a holmium laser system: procedural results and early clinical outcome. Catheter Cardiovasc Interv (1999) 1.40
Phylogenetic analysis of 70 kD heat shock protein sequences suggests a chimeric origin for the eukaryotic cell nucleus. Curr Biol (1994) 1.40
"Blocked" epidural catheter: another cause. Anesth Analg (2001) 1.40
Receptor for motilin identified in the human gastrointestinal system. Science (1999) 1.39
Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard. J Assoc Physicians India (1991) 1.39
Story of heparin recall: what India can do? J Postgrad Med (2008) 1.39
Paracetamol-associated coma, metabolic acidosis, renal and hepatic failure. Intensive Care Med (1988) 1.39
Primary stenting in acute myocardial infarction: a 30-day follow up study. Catheter Cardiovasc Interv (1999) 1.39
Fate and interconversion of endosulfan I, II and sulfate on gram crop (Cicer arietinum Linn.) in subtropical environment. Bull Environ Contam Toxicol (1991) 1.38
Giant cell tumour of short bones of hand. J Indian Med Assoc (1995) 1.38
FDG-PET/CT in diagnosis and early response evaluation of extra-pulmonary tuberculosis in a patient with aplastic anemia. J Postgrad Med (2010) 1.38
Intravenous drips. Trop Doct (1993) 1.38
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler (2009) 1.38
Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus. Am J Obstet Gynecol (1976) 1.37
Hürthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol (2001) 1.37
Basaloid squamous cell carcinoma of the head and neck. Laryngoscope (2000) 1.36
Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke (2001) 1.36
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product. Cell (1990) 1.35
Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. J Altern Complement Med (2001) 1.34
Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res Treat (2001) 1.34
Dissipation kinetics of spiromesifen on tea (Camellia sinensis) under tropical conditions. Chemosphere (2007) 1.34
Case report of a dermoid cyst at the floor of the mouth. Ann Acad Med Singapore (2004) 1.33